Penumbra (PEN) vs Zimmer Biomet (ZBH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Penumbra (PEN) has outperformed Zimmer Biomet (ZBH) over the past year, gaining 22.6% versus a loss of 9.6%. Over five years, PEN leads with a +18.6% price change compared with -37.5% for ZBH. Zimmer Biomet is the larger company by market cap ($16.95 billion vs $12.51 billion), about 1.4 times the size, while Penumbra is growing revenue faster (+17.5% vs +7.2%).
On valuation, Zimmer Biomet trades at a lower forward P/E (9.8x vs 51.8x for Penumbra). Zimmer Biomet pays a dividend yielding 1.08%, while Penumbra does not currently pay one. Penumbra converts more of its revenue into profit, with a net margin of 12.7% versus 8.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PEN | ZBH |
|---|---|---|
| Share price | $317.52 | $88.88 |
| Market cap | $12.51B | $16.95B |
| 1-day change | +0.37% | +0.44% |
| YTD return | +2.13% | -1.16% |
| 1-year return | +22.62% | -9.64% |
| 5-year return | +18.59% | -37.45% |
| P/E ratio (TTM) | 78.01 | 21.57 |
| Forward P/E | 51.78 | 9.80 |
| EPS (TTM) | $4.07 | $4.12 |
| Dividend yield | 0.00% | 1.08% |
| Annual dividend | $0.00 | $0.96 |
| Revenue (latest FY) | $1.40B | $8.23B |
| Revenue growth (YoY) | +17.50% | +7.20% |
| Net income (latest FY) | $177.69M | $705.10M |
| Gross margin | 67.14% | 69.71% |
| Operating margin | 13.48% | 13.34% |
| Net margin | 12.66% | 8.57% |
| 52-week high | $362.41 | $106.88 |
| 52-week low | $221.26 | $79.12 |
| Distance from 52-week high | -12.39% | -16.84% |
| Analyst consensus | hold | buy |
| Avg. price target upside | +13.88% | +20.65% |
| Average volume | 348.57K | 2.17M |
| Shares outstanding | 39.39M | 190.74M |
| Employees | 4,700 | 17,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PEN has outperformed ZBH by 32.3 percentage points over the past year.
- Penumbra trades at a higher earnings multiple (78.0x vs 21.6x trailing P/E).
- Zimmer Biomet offers a meaningfully higher dividend yield (1.08% vs 0.00%).
- Penumbra grew revenue faster in its latest fiscal year (+17.50% vs +7.20%).
About Penumbra
PEN stock →Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.
Health Care · Medical/Dental Instruments · 4,700 employees
About Zimmer Biomet
ZBH stock →Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.
Health Care · Industrial Specialties · 17,000 employees
PEN vs ZBH FAQ
Which is bigger, Penumbra or Zimmer Biomet?
Zimmer Biomet (ZBH) is larger, with a market capitalization of $16.95B compared with $12.51B for Penumbra (PEN).
Which stock has performed better over the past year, PEN or ZBH?
PEN returned +22.62% over the past 12 months, compared with -9.64% for ZBH (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, PEN or ZBH?
ZBH has the lower trailing P/E at 21.6, versus 78.0 for PEN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Penumbra or Zimmer Biomet?
Zimmer Biomet pays a dividend yielding 1.08%, while Penumbra does not currently pay a regular dividend.
Are Penumbra and Zimmer Biomet in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Penumbra and Industrial Specialties for Zimmer Biomet.